Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: WESTAT, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Navy
Period of performance: 2020-09-25 to 2023-12-24
Current total value of award: $3742407.5
Description: R&D OF AN INVESTIGATIONAL NEW DRUG (IND) SPONSOR, COMPLIANT CLINICAL TRIALS LEADING TO A NEW INDICATION FOR VALPROIC ACID (VPA) FOR TREATMENT OF PATIENTS WITH SIGNIFICANT HEMORRHAGE, NAVAL MEDICAL RESEARCH CENTER